[Federal Register: May 31, 2006 (Volume 71, Number 104)]
[Notices]
[Page 30914-30917]
[DOCID:fr31my06-87]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. PF06-023]

Gulf South Pipeline Company, LP; Notice of Intent To Prepare an
Environmental Impact Statement for the Proposed Mississippi Expansion
Project, Request for Comments on Environmental Issues, and Notice of
Public Scoping Meetings

May 23, 2006.
    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) will prepare an environmental impact statement (EIS) that
will address the environmental impacts of the Mississippi Expansion
Project proposed by Gulf South Pipeline Company, LP (Gulf South). The
Commission will use the EIS in its decision-making process to determine
whether or not to authorize the project. This notice explains the
scoping process we \1\ will use to gather input from the public and
interested agencies on the project. Your input will help us determine
the issues that need to be evaluated in the EIS. Please note that the
scoping period will close on June 23, 2006.
---------------------------------------------------------------------------

    \1\ ``We,'' ``us,'' and ``our'' refer to the environmental staff
of the FERC's Office of Energy Projects.
---------------------------------------------------------------------------

    Comments may be submitted in written form or verbally. Further
details on how to submit written comments are provided in the Public
Participation section of this notice. Public scoping meetings are
designed to provide another opportunity to offer comments on the
proposed project. In lieu of sending written comments, we invite you to
attend the public scoping meetings we have scheduled as follows:

------------------------------------------------------------------------
             Date and time                           Location
------------------------------------------------------------------------
Monday June 12, 2006, 7 p.m. to 10 p.m.  Eagle Ridge Conference Center,
 (CST).                                   1500 Raymond Lake Road,
                                          Raymond, MS 39154. Phone: 601-
                                          857-7100.
Tuesday June 13, 2006, 7 p.m. to 10      Vicksburg Convention Center &
 p.m. (CST).                              Auditorium, 1600 Mulberry
                                          Street, Vicksburg, MS 39180.
                                          Phone: 1-866-822-6338.
------------------------------------------------------------------------

    Interested groups and individuals are encouraged to attend these
meetings and to present comments on the environmental issues they
believe should be addressed in the EIS. A transcript of each meeting
will be generated so that comments are accurately recorded.
    This notice is being sent to affected landowners; Federal, state,
and local government agencies; elected officials; environmental and
public interest groups; Native American tribes; other interested
parties; and local libraries and newspapers. We encourage government
representatives to notify their constituents of this planned project
and encourage them to comment on their areas of concern.
    If you are a landowner receiving this notice, you may be contacted
by a Gulf South representative about the acquisition of an easement to
construct, operate, and maintain the proposed project facilities. The
pipeline company would seek to negotiate a mutually acceptable
agreement. However, if the project is approved by the FERC, that
approval conveys with it the right of eminent domain. Therefore, if
easement negotiations fail to produce an agreement, the pipeline
company could initiate condemnation proceedings in accordance with
state law.
    A fact sheet prepared by the FERC entitled ``An Interstate Natural
Gas Facility on My Land? What Do I Need To Know?'' is available for
viewing on the FERC Internet Web site (http://www.ferc.gov). This fact

sheet addresses a number of typically asked questions, including the
use of eminent domain and how to participate in the FERC's proceedings.

Summary of the Proposed Project

    Gulf South proposes to construct, own, operate, and maintain a
natural gas pipeline to provide new pipeline capacity to transport
domestic onshore gas supplies to producers in eastern

Texas and northern Louisiana with an outlet for a significant portion
of their production from the Barnett Shale, Bossier Sand, and other
fields. The Mississippi Expansion Project would also provide additional
transportation option for natural gas delivered into the north central
Louisiana area. The Mississippi Expansion Project facilities would be
located in Richland and Madison Parishes, Louisiana, and in Warren,
Hinds, Copiah, and Simpson Counties, Mississippi.\2\ The general
location of the proposed pipeline is shown in the figure included as
Appendix 1.\3\
---------------------------------------------------------------------------

    \2\ FERC staff is currently reviewing another Gulf South
project, the Texas East Expansion Project (under pre-filing Docket
No. PF06-017-000), that would bring natural gas from Texas to the
starting point of the Mississippi Expansion Project.
    \3\ The appendices referenced in this notice are not being
printed in the Federal Register. Copies of all appendices, other
than Appendix 1 (maps), are available on the Commission's Web site
at the ``eLibrary'' link or from the Commission's Public Reference
Room, 888 First Street, NE., Washington, DC 20426, or call (202)
502-8371. For instructions on connecting to eLibrary refer to the
Public Participation section of this mail notice. Copies of the
appendices were sent to all those receiving this notice in the.
Request for detailed maps of the proposed facilities should be made
directly to Gulf South.
---------------------------------------------------------------------------

    The Mississippi Expansion Project facilities under FERC
jurisdiction would include:
     An approximately 88.7-mile-long, 42-inch-diameter natural
gas pipeline from Gulf South's East Texas Expansion Facility near Delhi
in Richland Parish, Louisiana, to an interconnection with Gulf South's
existing Index 130 transportation pipeline in Simpson County,
Mississippi.
     A new 40,311 horsepower (hp) Tallulah Compressor Station
at approximate milepost (MP) 18.4 in Madison Parish, Louisiana.
     Two meter and regulator stations at receipt points with
two intrastate pipelines, including:

--Texas Eastern M&R Station at MP 70.9 in Warren County, Mississippi.
--Gulf South M&R Station at the proposed pipeline's terminus with Gulf
South's Index 130 Pipeline at MP 88.7 in Simpson County, Mississippi.

     Five mainline valves and two launcher/receiver sites.
    The project would be designed and constructed to receive and
transport about 1.5 billion cubic feet of natural gas per day. Gulf
South proposes to have the project constructed and operational by
September 2007.

Land Requirements for Construction

    As proposed, the typical construction right-of-way for the project
pipeline would be 100 feet wide. Following construction, Gulf South
would retain a 60-foot-wide permanent right-of-way for operation of the
project. Additional, temporary extra workspaces beyond the typical
construction right-of-way limits would be required at certain feature
crossings (e.g., roads, railroads, wetlands, or waterbodies), in areas
with steep side slopes, or in association with special construction
techniques.
    Based on preliminary information, construction of the proposed
project facilities would affect a total of about 1,228 acres of land.
Following construction, about 645 acres would be maintained as
permanent right-of-way, and about 12.3 acres of land would be
maintained as new aboveground facility sites. The remaining 571 acres
of temporary workspace (including all temporary construction rights-of-
way, extra workspaces, and pipe storage and contractor yards) would be
restored and allowed to revert to its former use.

The EIS Process

    NEPA requires the Commission to take into account the environmental
impacts that could result from an action when it considers whether or
not an interstate natural gas pipeline should be approved. The FERC
will use the EIS to consider the environmental impact that could result
if the Gulf South project is authorized under section 7 of the Natural
Gas Act. NEPA also requires us to discover and address concerns the
public may have about proposals to be considered by the Commission.
This process is referred to as ``scoping.'' The main goal of the
scoping process is to focus the analysis in the EIS on the important
environmental issues. With this Notice of Intent (NOI), the Commission
staff is requesting public comments on the scope of the issues to be
addressed in the EIS. All comments received will be considered during
preparation of the EIS.
    In the EIS we will discuss impacts that could occur as a result of
the construction and operation of the proposed project under these
general headings:
     Geology and soils;
     Water resources;
     Wetlands and vegetation;
     Fish and wildlife;
     Threatened and endangered species;
     Cultural resources;
     Land use, recreation, and visual resources;
     Socioeconomics;
     Air quality and noise;
     Reliability and safety;
     Alternatives; and
     Cumulative impacts.
    In the EIS, we will also evaluate possible alternatives to the
proposed project or portions of the project, and make recommendations
on how to lessen or avoid impacts on affected resources.
    Our independent analysis of the issues will be included in a draft
EIS. The draft EIS will be mailed to Federal, state, and local
government agencies; elected officials; environmental and public
interest groups; Native American tribes; affected landowners;
commentors; other interested parties; local libraries and newspapers;
and the FERC's official service list for this proceeding. A 45-day
comment period will be allotted for review of the draft EIS. We will
consider all comments on the draft EIS and revise the document, as
necessary, before issuing a final EIS. We will consider all comments on
the final EIS before we make our recommendations to the Commission. To
ensure that your comments are considered, please follow the
instructions in the Public Participation section of this notice.
    Although no formal application has been filed, the FERC staff has
already initiated its NEPA review under its NEPA Pre-filing Process.
The purpose of the Pre-filing Process is to encourage the early
involvement of interested stakeholders and to identify and resolve
issues before an application is filed with the FERC.
    With this notice, we are asking federal, state, and local
governmental agencies with jurisdiction and/or special expertise with
respect to environmental issues to express their interest in becoming
cooperating agencies for the preparation of the EIS. These agencies may
choose to participate once they have evaluated the proposal relative to
their responsibilities. Agencies that would like to request cooperating
status should send a letter expressing that interest and expected level
of involvement to the Secretary of the Commission at the address
provided in the public participation section of this notice.

Currently Identified Environmental Issues

    We have already identified several issues that we think deserve
attention based on a preliminary review of the proposed facilities, the
environmental information provided by Gulf South, and early input from
intervenors. This preliminary list of issues may be changed based on
your comments and our analysis.
    Geology and Soils:

 Potential impacts to fossil fuel and non-fossil fuel mineral
resources.
--Impacts on agricultural, prime farmland, and pastureland soils.

--Impacts on Conservation Reserve Program and Wetland Reserve Program
soils.
--Impacts on unconsolidated soils with severe erosion potential.

    Water Resources and Wetlands:

--Potential effects on groundwater resources.
--Impacts on ephemeral, intermittent and perennial streams, including
the Bayou Macon, Joes Bayou, Tensas River, Bayou Despair, Mothiglam
Bayou, Brushy Bayou, Walnut Bayou, Big Black River, and Pearl River.
Potential impacts on waterbodies greater than 100 feet in width
including the Mississippi River.
--Impacts on wetlands.

    Vegetation and Wildlife:

--Impacts on vegetation.
--Impacts on wildlife, wildlife habitat, and fisheries.
--Potential impacts on federally and state-listed threatened and
endangered species.
--Potential impacts to the Tensas National Wildlife Refuge.

    Cultural Resources:

--Impacts on archaeological sites and other historic properties.

    Land Use, Recreation, and Visual Resources:

--Potential impacts to existing land uses, including residences,
suburban housing developments, cemeteries, agricultural lands,
orchards, and managed forested lands.
--Visual effects of the proposed Tallulah Compressor Station and M&R
Stations on surrounding areas.
--Potential impacts on the Natchez Trace Parkway.

    Socioeconomics:

--Potential impacts and benefits of construction workforce on local
housing, infrastructure, public services and economy.

    Air and Noise Quality:

--Effects on air and noise quality from construction and operation of
the Tallulah Compressor Station.

    Reliability and Safety:

--Public safety and potential hazards associated with the transport of
natural gas.

    Alternatives:

--Assessment of route variations and route alignments to reduce or
avoid environmental impacts.

    Cumulative Impacts:
--Assessment of the effect of the proposed project when combined with
other past, present, or reasonably foreseeable future actions in the
project area

Public Participation

    You can make a difference by providing us with your specific
comments or concerns about the proposed project. By becoming a
commentor, your concerns will be addressed in the EIS and considered by
the Commission. Your comments should focus on the potential
environmental effects, reasonable alternatives (including alternative
facility sites and pipeline routes), and measures to avoid or lessen
environmental impact. The more specific your comments, the more useful
they will be. To ensure that your comments are timely and properly
recorded, please carefully follow these instructions:
     Send an original and two copies of your letter to: Magalie
R. Salas, Secretary, Federal Energy Regulatory Commission, 888 First
St., NE., Room 1A, Washington, DC 20426.
     Label one copy of your comments for the attention of Gas
Branch 2, DG2E.
     Reference Docket No. PF06-023 on the original and both
copies.
     Mail your comments so that they will be received in
Washington, DC on or before June 23, 2006.
    The Commission strongly encourages electronic filing of any
comments in response to this Notice of Intent. For information on
electronically filing comments, please see the instructions on the
Commission's Web site at http://www.ferc.gov under the ``e-Filing''

link and the link to the User's Guide, as well as information in 18 CFR
385.2001(a)(1)(iii). Before you can submit comments you will need to
create a free account, which can be created on-line.
    Once Gulf South formally files its application with the Commission,
you may want to become an official party to the proceeding known as an
``intervenor.'' Intervenors play a more formal role in the process and
are able to file briefs, appear at hearings, and be heard by the courts
if they choose to appeal the Commission's final ruling. An intervenor
formally participates in a Commission proceeding by filing a request to
intervene. Instructions for becoming an intervenor are included in the
User's Guide under the ``e-filing'' link on the Commission's Web site.
Please note that you may not request intervenor status at this time.
You must wait until a formal application is filed with the Commission.

Environmental Mailing List

    An effort is being made to send this notice to all individuals,
organizations, and government entities interested in and/or potentially
affected by the proposed project. This includes all landowners who are
potential right-of-way grantors, whose property may be used temporarily
for project purposes, or who own homes within distances defined in the
Commission's regulations of certain aboveground facilities.
    If you received this notice, you are on the environmental mailing
list for this project. If you do not want to send comments at this
time, but still want to remain on our mailing list, please return the
Information Request (Appendix 2). If you do not return the Information
Request, you will be removed from the Commission's environmental
mailing list.

Availability of Additional Information

    Additional information about the project is available from the
Commission's Office of External Affairs, at 1-866-208-FERC (3372) or on
the FERC Internet Web site (http://www.ferc.gov) using the ``eLibrary

link.'' Click on the eLibrary link, select ``General Search'' and enter
the project docket number excluding the last three digits (i.e., PF06-
23) in the ``Docket Number'' field. Be sure you have selected an
appropriate date range. For assistance, please contact FERC Online
Support at<EMAIL_ADDRESS>or toll free at 1-866-208-3676,
or TTY, contact<PHONE_NUMBER>. The eLibrary link on the FERC Internet
Web site also provides access to the texts of formal documents issued
by the Commission, such as orders, notices, and rule makings.
    In addition, the FERC now offers a free service called
eSubscription that allows you to keep track of all formal issuances and
submittals in specific dockets. This can reduce the amount of time you
spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. To register for this service, go to http://www.ferc.gov/esubscribenow.htm
.

    Public meetings or site visits will be posted on the Commission's
calendar located at http://www.ferc.gov/EventCalendar/EventsList.aspx

along with other related information.
    Finally, Gulf South has established an Internet Web site for this
project: http://www.gulfsouthpl.com/. You can also request additional

information or provide comments directly to Gulf South at 1-877/972-
8533 or Stephens,

Kyle (Gulf South<EMAIL_ADDRESS>
Magalie R. Salas,
Secretary.
[FR Doc. E6-8330 Filed 5-30-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 81, Number 170 (Thursday, September 1, 2016)]
[Notices]
[Pages 60358-60359]
[FR Doc No: 2016-21045]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-1660]

Microbiology Devices Panel of the Medical Devices Advisory
Committee; Notice of Meeting; Establishment of a Public Docket; Request
for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; establishment of a public docket; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming
public advisory committee meeting of the Microbiology Devices Panel of
the Medical Devices Advisory Committee. The general function of the
committee is to provide advice and recommendations to the Agency on
FDA's regulatory issues. The meeting will be open to the public. FDA is
establishing a docket for public comment on this document.

DATES: The meeting will be held on October 5, 2016, from 8 a.m. to 6
p.m.

ADDRESSES: Gaithersburg Holiday Inn, Ballroom, Two Montgomery Village
Ave., Gaithersburg, MD 20879. The hotel's telephone number is 301-948-
8900. Answers to commonly asked questions including information
regarding special accommodations due to a disability, visitor parking,
and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm. You may
submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2016-N-1660 for ``Microbiology Devices Panel of the Medical Devices
Advisory Committee; Notice of Meeting; Establishment of a Public
Docket; Request for Comments.'' Received comments will be placed in the
docket and, except for those submitted as ``Confidential Submissions,''
publicly viewable at http://www.regulations.gov or at the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Aden Asefa, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 2648, Silver Spring, MD 20993,
<EMAIL_ADDRESS>301-796-0400, or FDA Advisory Committee
Information Line, 1-800-741-8138<PHONE_NUMBER> in the Washington, DC
area). A notice in the Federal Register about last minute modifications
that impact a previously announced advisory committee meeting cannot
always be published quickly

enough to provide timely notice. Therefore, you should always check the
Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm
and scroll down to the appropriate advisory committee meeting link, or
call the advisory committee information line to learn about possible
modifications before coming to the meeting.

SUPPLEMENTARY INFORMATION:
    Agenda: On October 5, 2016, during session I, the topic to be
addressed will be reclassification of quantitative Cytomegalovirus
(CMV) viral load devices from class III (Premarket approval) to class
II (510(k)). A nucleic acid-based in vitro diagnostic device for the
quantitation of CMV viral load, within the context of transplant
patient management, is a post-amendment device classified into class
III under section 513(f)(1) of the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 360c(f)(1)). To date, the following product code has been
established for CMV viral load devices: PAB (Cytomegalovirus (CMV) DNA
Quantitative Assay). During session II, the topics to be addressed
include appropriate initial classification for qualitative or
quantitative viral load devices for Epstein-Barr virus (EBV), BK virus
(BK), JC virus (JCV), Human Herpesvirus 6 (HHV6), and Adenovirus
infections. FDA is seeking expert recommendations to assess the
potential risks and benefits of these devices when used in patients
following solid-organ or stem cell transplantation.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting
link.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
September 29, 2016. Oral presentations from the public will be
scheduled on October 5, 2016, between approximately 1 p.m. and 2 p.m.
Those individuals interested in making formal oral presentations should
notify the contact person and submit a brief statement of the general
nature of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
September 21, 2016. Time allotted for each presentation may be limited.
If the number of registrants requesting to speak is greater than can be
reasonably accommodated during the scheduled open public hearing
session, FDA may conduct a lottery to determine the speakers for the
scheduled open public hearing session. The contact person will notify
interested persons regarding their request to speak by September 22,
2016.
    Persons attending FDA's advisory committee meetings are advised
that the Agency is not responsible for providing access to electrical
outlets.
    FDA is establishing a docket for public comment on this document.
The docket number is FDA-2016-N-1660. The docket will close on November
9, 2016. Comments received on or before September 21, 2016, will be
provided to the committee. Comments received after that date will be
taken into consideration by the Agency.
    For press inquiries, please contact the Office of Media Affairs at
<EMAIL_ADDRESS>or<PHONE_NUMBER>.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
disabilities. If you require accommodations due to a disability, please
contact Artair Mallett at<EMAIL_ADDRESS>or<PHONE_NUMBER>,
at least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: August 26, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-21045 Filed 8-31-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: September 28, 2007 (Volume 72, Number 188)]
[Corrections]
[Page 55278-55279]
[DOCID:fr28se07-163]

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Parts 60 and 75

[EPA-HQ-OAR-2007-0164, FRL-8459-8]
RIN 2060-AO01

Two Optional Methods for Relative Accuracy Test Audits of Mercury
Monitoring Systems Installed on Combustion Flue Gas Streams and Several
Amendments to Related Mercury Monitoring Provisions

Correction

    In rule document 07-4147 beginning on page 51494 in the issue of
Friday, September 7, 2007, make the following corrections:

Appendix A-8 to Part 60 [Corrected]

    1. On page 51507, in Appendix A-8 to Part 60, in Method 30A, in
section 9.0, in the fourth column of the table, in the tenth line from
the bottom of the column, ``percentages..'' should read
``percentages.''.
    2. On the same page, in the same appendix, in the same section, in
the fifth column of the table, in the third line from the bottom of the
column, ``initial dynamic'' should read ``initial run; dynamic''.
    3. On page 51508, in the same appendix, in the same section, in the
table, entry ``A'' is corrected to read as follows:

                                 Summary Table of QA/QC Requirements--Continued
----------------------------------------------------------------------------------------------------------------
                                                                                Acceptance
           Status\1\             Process or element     QA/QC specification       criteria    Checking frequency
----------------------------------------------------------------------------------------------------------------
                                                  * * * * * * *
A..............................  Sample Point        Stratification Test (See  If the Hg      Prior to first
                                  Selection                  Section 8.1.3).    concentratio   run.
                                                                                n\2\ at each  Prior to 1/1/09,
                                                                                traverse       you may (1) forgo
                                                                                point during   stratification
                                                                                the            testing and use 3
                                                                                stratificati   sampling points
                                                                                on test is:    (as per Section
                                                                                <IP_ADDRESS>.2) or (2)
                                                                                Within < plus-  perform a SO2
                                                                                minus>5% of    stratification
                                                                                mean, use 1-   test (see
                                                                                point          Sections <IP_ADDRESS>
                                                                                sampling (at   and <IP_ADDRESS> of
                                                                                the point      appendix A to
                                                                                closest to     part 75), in lieu
                                                                                the mean);     of a Hg
                                                                                or             stratification
                                                                                Not    test. If the test
                                                                                within < plus-  location is
                                                                                minus>5% of    unstratified or
                                                                                mean, but is   minimally
                                                                                within < plus-  stratified for
                                                                                minus>10% of   SO2, it can be
                                                                                mean, use 3-   considered
                                                                                point          unstratified or
                                                                                sampling.      minimally
                                                                                Locate         stratified for Hg
                                                                                points         also.
                                                                                according to
                                                                                Section
                                                                                <IP_ADDRESS>.2 of
                                                                                this method.
                                                                               Alternatively
                                                                                , if the Hg
                                                                                concentratio
                                                                                n at each
                                                                                point is:

                                                                                Within < plus-
                                                                                minus>0.2
                                                                                [mu]g/m\3\
                                                                                of mean, use
                                                                                1-point
                                                                                sampling (at
                                                                                the point
                                                                                closest to
                                                                                the mean);
                                                                                or
                                                                                Not
                                                                                within < plus-
                                                                                minus>0.2
                                                                                [mu]g/m\3\
                                                                                of mean, but
                                                                                is within
                                                                                < plus-
                                                                                minus>0.5
                                                                                [mu]g/m\3\
                                                                                of mean, use
                                                                                3-point
                                                                                sampling.
                                                                                Locate
                                                                                points
                                                                                according to
                                                                                Section
                                                                                <IP_ADDRESS>.2 of
                                                                                this method.
                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------

    4. On page 51509, in the same appendix, in section 12.1, in the
first column, in the 13th line from the bottom of the column,
``Cbaseline'' should read ``Cbaseline''.
    5. On the same page, in the same appendix, in the same section, in
the third column, in the 16th line, ``%;.'' should read ``%.''.
    6. On the same page, in the same appendix, in the same section, in
the same column, in the 17th and 18th lines, ``R= Mean value of spike
recoveries at a particular target level, %;.'' should read ``R = Mean
value of spike recoveries at a particular target level, %.''.
    7. On the same page, in the same appendix, in the same section, in
the same column, in the 19th line, ``%;.'' should read ``%.''.
    8. On page 51522, in the same appendix, in Method 30B, in section

9.0, in the table, in the second column, in the last two lines of the
column, ``<10% of section 1 Hg mass for Hg concentrations > 1 [mu]g/
dscm;.'' should read ``< =10% of section 1 Hg mass for Hg concentrations
> 1 [mu]g/dscm;''.

Appendix B to Part 60 [Corrected]

    9. On page 51527, in Appendix B to Part 60, in the second column,
in section <IP_ADDRESS>, in the third line ``Eq. 12A-1'' should read ``(Eq.
12A-1)''.

Appendix K to Part 75 [Corrected]

    10. On page 51530, in Appendix K to Part 75, in section 8.0, in the
table, in the third column, in the 13th line, ``analyzing field.''
should read ``analyzing field samples.''.
    11. On the same page, in the same appendix, in the same section, in
the same table, in the fourth column, in the third line, ``Sample check
invalidated'' should read ``Sample invalidated''.
    12. On the same page, in the same appendix, in the same section, in
the same table, in the same column, in the 12th and 13th lines,
``analysis samples until successful'' should read ``analysis until
successful''.

[FR Doc. C7-4147 Filed 9-27-07; 8:45 am]

BILLING CODE 1505-01-D